Technology & Methodology

Diagnostic & Prognostic Tools for Personalized Medicine

Our novel, proprietary technology analyzes a specific part of an individual’s unique DNA (their telomeres) to determine how a disease will progress and if a patient will respond to treatment.

This information enables clinicians to measure the appropriateness and effectiveness of different treatments for specific patients.

About 3D Telomere Analysis

Product Pipeline

3D Signatures is currently developing 6 diagnostic and prognostic products for cancers and neurological disorders.

TARGET TEST RESEARCH DEVELOPMENT VALIDATION MARKET
Hodgkin’s Lymphoma 3D telo-HL      
Prostate Cancer 3D Telo-PC      
Multiple Myeloma 3D Telo-MM      
Breast Cancer 3D Telo-BC      
Lung Cancer 3D Telo-LC      
Alzheimer’s 3D Telo-AD